DNA/RNA Sequencing Technique Offers Hope to Drug-Resistant Multiple Myeloma Patients

Researchers from the Icahn School of Medicine at Mount Sinai say they have developed a RNA and DNA sequencing platform that benefits late-stage and drug-resistant multiple myeloma patients by determining which drugs would work best for them.The team described its methodology (“ Precision Medicine for Relapsed Multiple Myeloma on the Basis of an Integrative Multiomics Approach ”) in JCO Precision Oncology. “Multiple myeloma (MM) is a malignancy of plasma cell